DOI: 10.4244/EIJV8SPA1

In memoriam: Geoffrey O. Hartzler

Antonio Colombo; MD

Geoffrey Hartzler began his career as an electrophysiologist at the Mayo Clinic in 1974. In 1980 he moved to Kansas City where he established one of the most advanced PTCA programmes in the United States. He was the first interventionalist who challenged Andreas Gruentzig by extending the indications of balloon angioplasty into multivessel disease, chronic total occlusion and acute myocardial infarction, opening the door to primary PCI. The style of Geoffrey Hartzler was unique and provocative, questioning the value of measuring final gradients across stenosis in order to evaluate PTCA results and favouring angiographic assessment. This led to the development of an array of ultra-low profile balloon systems including fixed balloon catheters that, while unsuited to measure gradients, were able to be negotiated in vessels and to lesions at that time considered unapproachable. This unconventional practice generated vivid critiques that did not hamper the progress of his clinical contribution.

Geoffrey Hartzler was the first to establish an active primary PCI programme in Kansas City. He was the first to have the intuition that a mechanical treatment was the most effective tool to open acutely occluded vessels during myocardial infarction. At that time, thrombolytic therapy was emerging as the new treatment for myocardial infarction, and intracoronary thrombolysis, with the possibility of adjunctive mechanical disruption of the thrombus with a wire, was the most active interventional approach promoted. Primary angioplasty was born and in the initial publication of his experience1 he reported results in 78 out of his first consecutive 1,000 PTCA procedures, performed mainly in the setting of acute myocardial infarction without previous or concomitant streptokinase infusion.

Beyond direct patient care, Geoff Hartzler established a series of teaching courses with live transmissions and recorded cases which contributed to the education of interventional cardiologists throughout the world. The recorded cases were the ideal and unique way to teach primary angioplasty, which obviously is difficult to be programmed in the schedule of a predetermined meeting. A well-established tradition in his Kansas City group was to give a three-day intensive course in Hawaii with no invited faculty, no formal lectures and only a large series of recorded cases lively commented on by Geoffrey Hartzler and his associates. I have vivid memories of some of these challenging cases at a time when aspirin and heparin were the only possible pharmacological adjuvant therapy.

The devotion of Geoffrey Hartzler to direct patient care and frontline teaching along with his absolute faith in the self-evident merit of the results achieved were an obstacle to his entering the academic arena and designing studies comparing primary angioplasty with thrombolytic therapy. We had to wait until a decade later for the studies of Zijlstra et al and Grines et al in order to see large prospective studies convincingly demonstrating that primary angioplasty was superior to thrombolysis.

Severe spine injury prevented Geoff Hartzler from continuing to practice in the mid-90s, long before his premature death on March 10, 2012. Still his 15 years of innovative work ensured him an enduring legacy. William O’Neill, the last author of the US randomised study PAM I in primary angioplasty, openly admitted that the three weeks he spent watching procedures in Kansas City greatly inspired him to work in this direction. Interventional cardiology would not have reached our current level of achievement today without the effort and the vision of Geoffrey Hartzler.

Reference

Volume 8 Supplement P
Aug 25, 2012
Volume 8 Supplement P
View full issue


Key metrics

Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved